Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 1 | 1635 | 1328 | 0.0939 | 0.0728 | 0.8122 | 0.8214 |
COLO 858 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 3 | 977 | 819 | 0.0483 | 0.0728 | 0.8383 | 0.8214 |
COLO 858 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 2 | 1336 | 1087 | 0.0761 | 0.0728 | 0.8136 | 0.8214 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1125 | 559 | 0.1021 | 0.0736 | 0.4969 | 0.5166 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 3 | 601 | 317 | 0.0512 | 0.0736 | 0.5275 | 0.5166 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 2 | 788 | 414 | 0.0674 | 0.0736 | 0.5254 | 0.5166 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1274 | 753 | 0.0744 | 0.0748 | 0.5911 | 0.5989 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1297 | 782 | 0.0736 | 0.0748 | 0.6029 | 0.5989 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1347 | 812 | 0.0764 | 0.0748 | 0.6028 | 0.5989 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1554 | 62 | 0.0781 | 0.0757 | 0.0399 | 0.0403 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1649 | 67 | 0.0828 | 0.0757 | 0.0406 | 0.0403 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1316 | 53 | 0.0661 | 0.0757 | 0.0403 | 0.0403 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 1 | 1468 | 1062 | 0.0932 | 0.0767 | 0.7234 | 0.7291 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 2 | 1263 | 917 | 0.0794 | 0.0767 | 0.7260 | 0.7291 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 3 | 957 | 706 | 0.0576 | 0.0767 | 0.7377 | 0.7291 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 1 | 972 | 720 | 0.0765 | 0.0787 | 0.7407 | 0.7868 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1300 | 1033 | 0.0810 | 0.0787 | 0.7946 | 0.7868 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1480 | 1221 | 0.0786 | 0.0787 | 0.8250 | 0.7868 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 1035 | 564 | 0.0849 | 0.0793 | 0.5449 | 0.5384 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 956 | 466 | 0.0884 | 0.0793 | 0.4874 | 0.5384 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 858 | 500 | 0.0646 | 0.0793 | 0.5828 | 0.5384 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1899 | 295 | 0.0769 | 0.0825 | 0.1553 | 0.1694 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 2204 | 325 | 0.0900 | 0.0825 | 0.1475 | 0.1694 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2119 | 435 | 0.0807 | 0.0825 | 0.2053 | 0.1694 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 3 | 1002 | 665 | 0.0773 | 0.0829 | 0.6637 | 0.6809 |